Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
Janice Soo Fern Lee1, Alexandra Calmy1,2, Isabelle Andrieux-Meyer1, Nathan Ford1,31Médecins Sans Frontières, 2HIV/AIDS Unit, Infectious Disease Service, Geneva University Hospital, Geneva, Switzerland; 3Centre for Infectious Disease Epidemiology and Research, University...
Guardado en:
Autores principales: | Lee JSF, Calmy A, Andrieux-Meyer I, Ford N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c808f918c524a758afdb0a759814e85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
por: Ford N, et al.
Publicado: (2011) -
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
por: Pandey KK
Publicado: (2014) -
Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings
por: Scanlon ML, et al.
Publicado: (2013) -
Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi A, et al.
Publicado: (2013) -
Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani I, et al.
Publicado: (2013)